1. Home
  2. NLSP vs WATT Comparison

NLSP vs WATT Comparison

Compare NLSP & WATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • WATT
  • Stock Information
  • Founded
  • NLSP 2015
  • WATT 2012
  • Country
  • NLSP Switzerland
  • WATT United States
  • Employees
  • NLSP N/A
  • WATT N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • WATT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • NLSP Health Care
  • WATT Technology
  • Exchange
  • NLSP Nasdaq
  • WATT Nasdaq
  • Market Cap
  • NLSP 8.2M
  • WATT 6.9M
  • IPO Year
  • NLSP 2021
  • WATT 2014
  • Fundamental
  • Price
  • NLSP $0.19
  • WATT $0.87
  • Analyst Decision
  • NLSP Hold
  • WATT Strong Buy
  • Analyst Count
  • NLSP 1
  • WATT 2
  • Target Price
  • NLSP N/A
  • WATT $2.25
  • AVG Volume (30 Days)
  • NLSP 11.0M
  • WATT 71.2K
  • Earning Date
  • NLSP 07-30-2024
  • WATT 08-08-2024
  • Dividend Yield
  • NLSP N/A
  • WATT N/A
  • EPS Growth
  • NLSP N/A
  • WATT N/A
  • EPS
  • NLSP N/A
  • WATT N/A
  • Revenue
  • NLSP N/A
  • WATT $441,508.00
  • Revenue This Year
  • NLSP N/A
  • WATT $98.44
  • Revenue Next Year
  • NLSP N/A
  • WATT $317.66
  • P/E Ratio
  • NLSP N/A
  • WATT N/A
  • Revenue Growth
  • NLSP N/A
  • WATT N/A
  • 52 Week Low
  • NLSP $0.11
  • WATT $0.63
  • 52 Week High
  • NLSP $1.21
  • WATT $5.60
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 49.01
  • WATT 26.28
  • Support Level
  • NLSP $0.19
  • WATT $0.90
  • Resistance Level
  • NLSP $0.24
  • WATT $1.11
  • Average True Range (ATR)
  • NLSP 0.03
  • WATT 0.11
  • MACD
  • NLSP -0.00
  • WATT -0.00
  • Stochastic Oscillator
  • NLSP 15.85
  • WATT 49.71

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About WATT Energous Corporation

Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. Its products include Transmitter IC & Module, Receivers IC, Transmitter System and other tools.

Share on Social Networks: